PD
Purshottam Dattatraya Yedurkar
About Purshottam Dattatraya Yedurkar
Data last updated:
Purshottam Dattatraya Yedurkar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Apt Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Apt Pharmaceutical Private Limited at ₹2.66 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apt Pharmaceutical Private Limited U24239MH2022PTC387785 | Director | 28 Jul 2022 | 2022 | ₹2.66 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Purshottam Dattatraya Yedurkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Purshottam Dattatraya Yedurkar
Purshottam Dattatraya Yedurkar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Apt Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Apt Pharmaceutical Private Limited at ₹2.66 Cr (FY 2025).
Purshottam Dattatraya Yedurkar is associated with 1 company as Director, including Apt Pharmaceutical Private Limited (₹2.66 Cr).
Purshottam Dattatraya Yedurkar has expertise in General Business.
Purshottam Dattatraya Yedurkar has 4 years in corporate governance.
By reported revenue, the largest current company of Purshottam Dattatraya Yedurkar is Apt Pharmaceutical Private Limited, with revenue of ₹2.66 Cr (FY 2025).
Purshottam Dattatraya Yedurkar currently holds positions at 1 company: Apt Pharmaceutical Private Limited (₹2.66 Cr).